Connect your AI

Indivior Pharmaceuticals, Inc. INDV Inventories

Inventories at other companies

AlkermesALKS

$336.7M+83.6%

Other financials

Income statement

Revenue$317.0M+19.2%

Gross profit$277.0M+24.8%

Operating income$137.0M+108%

Net income$89.0M+89.4%

EPS (diluted)$0.69+81.6%

Balance sheet

Cash & equivalents$175.0M-53.0%

Total debt$509.0M+37.6%

Total equity-$144.0M+49.5%

Total assets$1.2B-12.9%

Cash flow

Operating cash flow-$9.0M-112%

CapEx$20.0M+300%

Free cash flow-$29.0M-141%

Valuation

Market cap$4.53B+213%

Profitability

Gross margin81.3%+1.5pp

Operating margin25.8%+23.3pp

Net margin19.4%+18.9pp

FCF margin-14.9%—

Returns & leverage

Current ratio0.9×0.0×

Where this comes from

Reported directly by Indivior Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InventoryNoncurrent.

The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Indivior Pharmaceuticals, Inc. 's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Indivior Pharmaceuticals, Inc. 's inventories?: Indivior Pharmaceuticals, Inc. (INDV) reported inventories of $1M in Q1 2026.
How has Indivior Pharmaceuticals, Inc. 's inventories changed year-over-year?: Indivior Pharmaceuticals, Inc. 's inventories decreased by 91.7% year-over-year, from $12M to $1M.
What is the long-term trend for Indivior Pharmaceuticals, Inc. 's inventories?: Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's inventories has grown at a 2.2% compound annual growth rate (CAGR), from $30M to $32M.
What does inventories mean?: Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.